Current approaches in treatment of triple-negative breast cancer
Triple-negative breast cancer (TNBC) is diagnosed more frequently in younger and premenopausal women and is highly prevalent in African American women. TNBC is a term derived from tumors that are characterized by the absence of ER, PgR, and HER2. So patients with TNBC do not benefit from hormonal or...
Main Authors: | Hanan Ahmed Wahba, Hend Ahmed El-Hadaad |
---|---|
Format: | Article |
Language: | English |
Published: |
China Anti-Cancer Association
2015-06-01
|
Series: | Cancer Biology & Medicine |
Subjects: | |
Online Access: | http://www.cancerbiomed.org/index.php/cocr/article/view/849 |
Similar Items
-
Clinical characteristics of triple negative breast cancer in Egyptian women: a hospital-based experience
by: Nivine Gado, et al.
Published: (2016-06-01) -
Triple-negative and HER2-overexpressing breast cancer cell sialylation impacts tumor microenvironment T-lymphocyte subset recruitment: a possible mechanism of tumor escape
by: Garbar C, et al.
Published: (2018-05-01) -
Triple Negative Breast Cancer-An Overview and Review of Literature
by: Amit Gupta
Published: (2013-02-01) -
Hormonal Receptors, Human Epidermal Growth Factor Receptor-2 and Triple Negative Immunohistochemical Typing in Women with Breast Cancer in Kampala, Uganda
by: Mlole AT, et al.
Published: (2020-11-01) -
Current and emerging treatment options in triple-negative breast cancer
by: Omer Dizdar, et al.
Published: (2011-12-01)